Latest News

Dutch set to win EU nod for $2.2 bln state help for brand-new atomic power plant

The Dutch federal government is set to protect EU approval for 2 billion euros ($ 2.2 billion) of state aid to develop an atomic power plant to produce medical isotopes for cancer treatment, people with direct understanding of the matter said on Thursday.

The European Commission approval is conditional on a pledge from the Dutch federal government that the medical isotopes would not be offered below cost, individuals said, following a problem from U.S. maker of radioactive medical isotopes SHINE Technologies.

The EU executive, which acts as the bloc's competition enforcer, decreased to comment on its discussions with the Dutch authorities or the outcome or timing of the talks.

The Commission remains in close and positive discussions with the Dutch authorities as relates to public support to the PALLAS job with a view to ensuring the compatibility with the EU Treaties, while preventing undue distortions of competition in the production and supply of medical radioisotopes, a. Commission representative said.

The Dutch Ministry of Health, Well-being and Sport declined. comment.

The Netherlands, a leading manufacturer of medical isotopes,. proposed a new nuclear reactor for medical isotopes following. concerns that scarcities would emerge after 2030.

Government-subsidised companies must not be enabled to. block ingenious private-market solutions from serving clients. due to rates below cost due to unlawful aids, SHINE. Technologies stated in an email.

The U.S. business complained to the Commission in 2015,. stating that the Dutch state had no legal basis to grant state. help for the brand-new reactor.

(source: Reuters)